Health ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Phase III Trials Research Studies Randomized Controlled Trials Efficacy Studies Drug Approval Cancer Research

FDA Clears Moderna’s mFlusiva as First mRNA Seasonal Flu Vaccine for Adults 50 and Older

The approval creates a faster way to update seasonal and pandemic flu shots pending CDC advisory guidance and vaccine procurement schedules.

Oral Fecal Microbiome Capsules Raise Peanut Tolerance in Small Phase I Trial

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

International Consortium Publishes 665 Validated Patient-Derived Cancer Models

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

MiNK Reports Early Phase 2 Day‑28 Survival and Clinical Signals for Off‑the‑Shelf iNKT Therapy

FDA Approves Orzeyful as First Orexin Agonist for Narcolepsy Type 1

Moderna Starts Phase 1 Trial in Canada for Bundibugyo Ebola Vaccine

BioCryst Cuts Internal Discovery After Q2 ORLADEYO Gains and Pediatric Rollout

Eli Lilly Opens Limited Early Access to Experimental Obesity Drug Retatrutide

British Baby Receives Experimental In‑Womb Repair for Severe Gastroschisis

Large U.S. Trial Finds Silver Diamine Fluoride Stops Many Cavities in Young Children

Multiple Plaintiff Firms Seek Lead Role in GRAIL Securities Suit

Automated Oxygen Titration Boosts Time in Target Saturation but Shows No Proven Clinical Benefit

VA Launches Nationwide Trial Testing Semaglutide for Alcohol Use Disorder

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

Dexcom Beats Q2 Expectations and Lifts 2026 Outlook

Oral Semaglutide Linked to Fewer Heavy Drinking Days in Small Randomized Trial

FDA Advisers Find Replimune’s RP1 Trial Results Clinically Meaningful

Large U.S. Trial Shows Liquid Treatment Halts Decay in Over Half of Baby Teeth